Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults

被引:10
|
作者
Niznik, Joshua D. [1 ,2 ,3 ,4 ]
Ferreri, Stefanie P. [5 ]
Armistead, Lori T. [5 ]
Kelley, Casey J. [2 ]
Schlusser, Courtney [6 ]
Hughes, Tamera [5 ]
Henage, Cristine B. [2 ]
Busby-Whitehead, Jan [1 ,2 ]
Roberts, Ellen [1 ,2 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Div Geriatr Med, 5003 Old Clin,CB 7550, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, UNC Ctr Aging & Hlth, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC 27515 USA
[4] Vet Affairs VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15240 USA
[5] Univ N Carolina, Eshelman Sch Pharm, Div Practice Adv & Clin Educ, Chapel Hill, NC 27515 USA
[6] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
关键词
CONSULTANT PHARMACISTS; GENERAL-PRACTITIONERS; HEALTH; FALLS; MEDICATIONS;
D O I
10.1007/s40266-022-00967-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Purpose Opioids and benzodiazepines (BZDs) are frequently implicated as contributing to falls in older adults. Deprescribing of these medications continues to be challenging. This study evaluated primary-care prescribers' confidence in and perceptions of deprescribing opioids and BZDs for older adults. Methods For this study, we conducted a quantitative analysis of survey data combined with an analysis of qualitative data from a focus group. A survey evaluating prescriber confidence in deprescribing opioids and BZDs was distributed to providers at 15 primary-care clinics in North Carolina between March-December 2020. Average confidence (scale 0-100) for deprescribing opioids, deprescribing BZDs, and deprescribing under impeding circumstances were reported. A virtual focus group was conducted in March 2020 to identify specific barriers and facilitators to deprescribing opioids and BZDs. Audio recordings and transcripts were analyzed using inductive coding. Results We evaluated 61 survey responses (69.3% response rate). Respondents were predominantly physicians (54.8%), but also included nurse practitioners (24.6%) and physician assistants (19.4%). Average overall confidence in deprescribing was comparable for opioids (64.5) and BZDs (65.9), but was lower for deprescribing under impeding circumstances (53.7). In the focus group, prescribers noted they met more resistance when deprescribing BZDs and that issues such as lack of time, availability of mental health resources, and patients seeing multiple prescribers were barriers to deprescribing. Conclusion Findings from quantitative and qualitative analyses identified that prescribers were moderately confident in their ability to deprescribe both opioids and BZDs in older adults, but less confident under potentially impeding circumstances. Future studies are needed to evaluate policies and interventions to overcome barriers to deprescribing opioids and BZDs in primary care.
引用
收藏
页码:739 / 748
页数:10
相关论文
共 50 条
  • [1] Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
    Joshua D. Niznik
    Stefanie P. Ferreri
    Lori T. Armistead
    Casey J. Kelley
    Courtney Schlusser
    Tamera Hughes
    Cristine B. Henage
    Jan Busby-Whitehead
    Ellen Roberts
    [J]. Drugs & Aging, 2022, 39 : 739 - 748
  • [2] Deprescribing Opioids and Benzodiazepines: Perspectives of Older Adults
    Niznik, J. D.
    Kelley, C. J.
    Ferreri, S.
    Armistead, L.
    Schlusser, C.
    Hughes, T.
    Henage, C.
    Busby-Whitehead, J.
    Roberts, E.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S86 - S86
  • [4] A CONSULTANT PHARMACIST INTERVENTION TO DEPRESCRIBE OPIOIDS AND BENZODIAZEPINES FOR OLDER ADULTS IN PRIMARY CARE
    Niznik, Joshua
    Busby-Whitehead, Jan
    Armistead, Lori
    Urick, Benjamin
    Zhao, Liang
    Ferreri, Stefanie
    [J]. INNOVATION IN AGING, 2023, 7 : 699 - 699
  • [5] Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines
    Hawkins, Eric J.
    Lott, Aline M.
    Danner, Anissa N.
    Malte, Carol A.
    Hagedorn, Hildi J.
    Berger, Douglas
    Donovan, Lucas M.
    Sayre, George G.
    Mariano, Anthony J.
    Saxon, Andrew J.
    [J]. PAIN MEDICINE, 2021, 22 (07) : 1559 - 1569
  • [6] Pharmacist-Led Deprescribing of Opioids and Benzodiazepines in Older Adults: Examining Implementation and Perceptions
    Hughes, Tamera D.
    Sottung, Elizabeth
    Nowak, Juliet
    Sanders, Kimberly A.
    [J]. PHARMACY, 2024, 12 (04)
  • [7] Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain
    Anderson, Timothy S.
    Wang, Brianna X.
    Lindenberg, Julia H.
    Herzig, Shoshana J.
    Berens, Dylan M.
    Schonberg, Mara A.
    [J]. JAMA NETWORK OPEN, 2024, 7 (03) : E241342
  • [8] Older adults' perceptions of deprescribing chronic benzodiazepines
    Choi, Jae
    Vordenberg, Sarah E.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2021, 61 (05) : 533 - +
  • [9] Insights Gained on Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
    Hughes, T. D.
    Henage, C. B.
    Armistead, L.
    Niznik, J. D.
    Kelley, C. J.
    Schlusser, C.
    Busby-Whitehead, J.
    Ferreri, S.
    Roberts, E.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S195 - S195
  • [10] Pharmacist roles in deprescribing anticholinergics in primary care older adults
    Campbell, N. L.
    Pitts, C.
    Corvari, C.
    Kaehr, E.
    Alamer, K.
    Chand, P.
    Nanagas, K.
    Callahan, C.
    Boustani, M.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S60 - S61